GTC Biotherapeutics (fka GTCB)

[biopearl]

My error. Could in theory a phase IIb study (if extremly positive) serve as a basis for approval or is a phase III study always necessary. If for example a survival benefit were shown in spite of the original design that was not powered to do so. Thanks, bp